AstraZeneca

The FDA approved a self-administered flu vaccine, FluMist by AstraZeneca, available for home use by adults and children with caregiver assistance, to be accessible via online pharmacy for next year's flu season, aiming to enhance convenience and accessibility.

FDA approves Eli Lilly’s Ebglyss for eczema, Novartis’ Kisqali for early breast cancer, Merck’s Keytruda for malignant pleural mesothelioma, J&J’s Rybrevant for advanced lung cancer, and AstraZeneca’s Fasenra for eosinophilic granulomatosis with polyangiitis.

The FDA approved the first self-administered flu vaccine, FluMist by AstraZeneca, which will be available for home use next respiratory virus season. This nasal spray vaccine, already in use since 2003, aims to increase accessibility and convenience for vaccination, potentially boosting uptake among those hesitant due to needle phobia.

FDA approves first self-administered nasal spray flu vaccine, FluMist, for ages 2-49, requiring a prescription and potentially increasing convenience and accessibility.

FDA approves AstraZeneca’s FluMist, the first self-administered nasal influenza vaccine, available for online ordering and home use.

FDA approves AstraZeneca's FluMist nasal spray flu vaccine for self-administration, available online next fall. The needle-free spray, approved for ages 2-49, aims to increase seasonal flu vaccination rates.

FDA approves AstraZeneca's FluMist for at-home use in ages 2-49, aiming to increase flu vaccine accessibility and combat annual influenza burden.

FDA broadened approval of FluMist nasal spray for self-administration, making it the first influenza vaccine for home use, though availability is delayed until next flu season. AstraZeneca plans to sell FluMist directly to patients via an online pharmacy, pending prescription.

AstraZeneca's FluMist approved for self-administration in the US, making it the only influenza vaccine for home use. Adults aged 49 and under can self-administer, while caregivers can use it for children aged 2-17. FluMist's efficacy and safety in self-administration are similar to professional administration.